Journals / Van Tıp Dergisi / 2022 / Cilt: 29 - Sayı: 1

Investigation of Treatment Potential of O-Vanillin Containing Schiff Base Ligand and Pd(II) Complex in Glioblastoma Multiforme Cells and Efficiency of Electroporation

O-Vanilin İçeren Schiff Bazı Ligandı ve Pd(II) Kompleksinin Glioblastoma Multiforme Hücrelerindeki Tedavi Potansiyelinin İncelenmesi ve Elektroporasyonun Etkinliği

Pages
69–75
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the treatment of T98G GBM, the combined application of Pd(II) complex with EP was found to be much more effective than the application of Pd(II) complex alone (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Glioblastoma multiforme (GBM) is one of the most common and deadliest pr imary brain tumors.
📊
Key Findings & Data:Objective: The aim of this study was to investigate the chemotherapy potential of Meth yl 2-Amino-6-Methyl-4,5,6,7- Tetrahydrothieno[2,3-c] Pyridine-3-Carboxylate-based ligand and its Pd(II) complex in chemotherapy-resistant GBM cells and to investigate the efficacy of electroporation (EP) on the cytotoxicity of these compounds.
💡
Conclusion & Impact:In the treatment of T98G GBM, the combined application of Pd(II) complex with EP was found to be much more effective than the application of Pd(II) complex alone (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: Glioblastoma multiforme (GBM) is one of the most common and deadliest pr imary brain tumors. Despite standard treatments such as surg ical resection, radiation, and high-dose chemotherapy, the average survival time of patients after diagnosis is around twelve months. Objective: The aim of this study was to investigate the chemotherapy potential of Meth yl 2-Amino-6-Methyl-4,5,6,7- Tetrahydrothieno[2,3-c] Pyridine-3-Carboxylate-based ligand and its Pd(II) complex in chemotherapy-resistant GBM cells and to investigate the efficacy of electroporation (EP) on the cytotoxicity of these compounds. Material and Method: The cytotoxic activity of the ligand and Pd(II) complex was investigated against T98G human GBM cell line, while healthy fibroblast cells (L-929) was used for biocompatibility. The cytotoxici ties of Ligand and Pd(II) complex, alone or in combination with EP, were determined by MTT test. Results: Pd(II) complex showed good anti-cancer activity in T98G cells (IC50= 394.67), while it didn't show cytotoxic activity in L-929 fibroblast cells (IC50= 1449.28). The ligand showed cytotoxic activity at IC50= 1126.79 and IC50= 1283.36 levels in T98G and L-929 cell lines, respectively. In the treatment of T98G GBM, the combined application of Pd(II) complex with EP was found to be much more effective than the application of Pd(II) complex alone (p

Özet

Giriş: Glioblastoma multiforme (GBM) sık görülen ve en ölümcül primer beyin tümörlerindendir. Cerrahi rezeksiyon, radyasyon ve yüksek-doz kemoterapi gibi standart tedavilere rağmen, tan ı konulduktan sonra hastaların ortalama sağ kalım süresi on iki ay civarındadır. Amaç: Bu çalışmada, Metil 2-Amino-6-Metil-4,5,6,7- Tetrahidrotieno[2,3-c] Pi ridin-3-Karboksilat bazl ı ligand ve Pd(II) kompleksinin kemoterapiye dirençli GBM hücrelerindeki tedavi potansiyellerini araştırmak ve elektroporasyonun (EP) bu bileşiklerin sitotoksisiteleri üzerindeki etkinliğinin araştırılması amaçlanmıştır. Gereç ve Yöntem : Ligand ve Pd(II) kompleksinin sitotoksik aktivitesi T98G insan GBM hücre hatt ına kar şı araştırılırken, biyouyumluluk için sağlıklı fibroblast hücreleri (L-929) kullanıldı. MTT testi kullanılarak Ligand ve Pd(II) kompleksinin tek ba şına veya EP ile kombinasyon halindeki sitotoksisiteleri belirlendi. Bulgular: Pd(II) kompleksi T98G hücrelerinde iyi düzeyde anti- kanser aktivite gösterirken (IC 50= 394.67), L-929 fibroblast hücrelerinde sitotoksik aktivite göstermemiştir (IC50= 1449.28). Ligand ise T98G ve L-929 hücre hatlar ında s ırasıyla IC 50= 1126.79 ve IC50= 1283,36 düzeyinde sitotoksik aktivite göstermiştir. T98G GBM tedavisinde Pd(II) kompleksinin EP ile kombine uygulanması tek başına Pd(II) kompleksin uygulanmasından çok daha etkili olduğu tespit edilmiştir. Sonuç: Sağlıklı hücrelerde (L-929) sitotoksik aktivite göstermeyip, T98G hücre hatt ında sitotoksik aktivite gösteren Pd(II) kompleksi GBM tedavisi için olası kemoterapötik ajan olarak geliştirilebilir ve EP ile kombine kullanılması durumunda umut vaat eden sonuçlar verebilir.

🔖

Cite This Article

Alkış, M. E. (2022). Investigation of Treatment Potential of O-Vanillin Containing Schiff Base Ligand and Pd(II) Complex in Glioblastoma Multiforme Cells and Efficiency of Electroporation. Van Tıp Dergisi, Cilt: 29 - Sayı: 1, 69–75. https://ajindex.com/articles/645861

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Lah TT, Novak M, Pena Almidon MA, Marinelli O, Žvar Baškovič B, Majc B, et al. Cannabigerol is a potential therapeutic agent in a novel combined therapy for glioblastoma. Cells 2021; 10(2): 340
  2. Wang H, Zhou H, Xu J, Lu Y, Ji X, Yao Y, et al. Different T-cell subsets in glioblastoma multiforme and targeted immunotherapy. Cancer Lett 2021; 496: 134-43
  3. Nishikawa R. Standard therapy for glioblastoma- A review of where we are. Neurol Med Chir 2010; 50(9): 713-719
  4. Lee SY, Slagle-Webb B, Rizk E, Patel A, Miller PA, Sung S-S, et al. Characterization of a novel anti-cancer compound for astrocytomas. PLoS One 2014; 9(9): e108166
  5. Rahmouni A, Souiei S, Belkacem MA, Romdhane A, Bouajila J, Ben Jannet H. Synthesis and biological evaluation of novel pyrazolopyrimidines derivatives as anticancer and anti-5-lipoxygenase agents. Bioorg Chem 2016; 66: 160-168
  6. Elsey J, Bubley JA, Zhu L, Rao S, Sasaki M, Pollack BP, et al. Palladium based nanoparticles for the treatment of advanced melanoma. Sci Rep 2019; 9(1): 3255
  7. Campana LG, Miklav čič D, Bertino G, Marconato R, Valpione S, Imarisio I, et al. Electrochemotherapy of superficial tumors - Current status: Basic principles, operating procedures, shared indications, and emerging applications. Semin Oncol 2019; 46(2): 173-191
  8. Fiorentzis M, Viestenz A, Siebolts U, Seitz B, Coupland SE, Heinzelmann J. The potential use of electrochemotherapy in the treatment of uveal melanoma: In vitro results in 3D tumor cultures and in vivo results in a chick embryo model. Cancers (Basel) 2019; 11(9): 1344
  9. Batista Napotnik T, Miklav čič D. In vitro electroporation detection methods - An overview. Bioelectrochemistry 2018; 120: 166-182
  10. Frandsen SK, McNeil AK, Novak I, McNeil PL, Gehl J. Difference in membrane repair capacity between cancer cell lines and a normal cell line. J Membr Biol 2016; 249(4): 569-576
  11. Zielichowska A, Daczewska M, Saczko J, Michel O, Kulbacka J. Applications of calcium electroporation to effective apoptosis induction in fibrosarcoma cells and stimulation of normal muscle cells. Bioelectrochemistry 2016; 109: 70-78
  12. Arafath MA, Adam F, Razali MR, Ahmed Hassan LE, Ahamed MBK, Majid AMSA. Synthesis, characterization and anticancer studies of Ni(II), Pd(II) and Pt(II) complexes with Schiff base derived from N- methylhydrazinecarbothioamide and 2- hydroxy-5-methoxy-3-nitrobenzaldehyde. J Mol Struct 2017; 1130: 791-798
  13. Cemazar M, Sersa G. Recent advances in electrochemotherapy B